Eric Bjerkholt - 03 Feb 2025 Form 4 Insider Report for Metagenomi, Inc. (MGX)

Role
Director
Signature
/s/ Matthew L. Wein, attorney-in-fact
Issuer symbol
MGX
Transactions as of
03 Feb 2025
Net transactions value
$0
Form type
4
Filing time
05 Feb 2025, 16:24:01 UTC
Previous filing
27 Jan 2025
Next filing
15 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGX Stock Option (Right to Buy) Award $0 +42,000 $0.000000 42,000 03 Feb 2025 Common Stock 42,000 $2.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 33.33% of the shares subject to this option shall vest and become exercisable on February 3, 2026, with the remainder vesting in 24 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.